特异性抗体免疫组化法检测EGFR突变价值的meta分析
背景与目的已有的研究表明：表皮生长因子受体（epidermal growth factor receptor, EGFR）基因突变是非小细胞肺癌（non-small cell lung cancer, NSCLC）患者应用表皮生长因子受体酪氨酸激酶抑制剂（EGFR tyrosine kinase inhibitor, EGFR-TKI）治疗疗效的最重要的预测因子。EGFR基因突变的患者对于使用TKIs分子靶向药物治疗疗效更敏感。其突变检测对肺癌一线靶向治疗选择尤为关键。研究分析特异性抗体免疫组化法（immunohistochemistry, IHC）检测EGFR突变与DNA测序法比较的敏感度与...
Saved in:
| Published in | 中国肺癌杂志 Vol. 17; no. 6; pp. 451 - 459 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
天津医科大学总医院肿瘤科,天津,300052%300052天津，天津医科大学总医院，天津市肺癌研究所%300052天津，天津医科大学总医院肿瘤科
2014
300052天津，天津医科大学总医院，天津市肺癌研究所 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1009-3419 1999-6187 |
| DOI | 10.3779/j.issn.1009-3419.2014.06.03 |
Cover
| Abstract | 背景与目的已有的研究表明：表皮生长因子受体（epidermal growth factor receptor, EGFR）基因突变是非小细胞肺癌（non-small cell lung cancer, NSCLC）患者应用表皮生长因子受体酪氨酸激酶抑制剂（EGFR tyrosine kinase inhibitor, EGFR-TKI）治疗疗效的最重要的预测因子。EGFR基因突变的患者对于使用TKIs分子靶向药物治疗疗效更敏感。其突变检测对肺癌一线靶向治疗选择尤为关键。研究分析特异性抗体免疫组化法（immunohistochemistry, IHC）检测EGFR突变与DNA测序法比较的敏感度与特异度，明确该方法准确性及临床应用价值。方法通过Pubmed数据库检索所有符合检索条件的文献，末次检索日期2013年3月26日，根据纳入和排除标准进行进一步筛选，采用诊断试验meta分析方法，分析特异性抗体免疫组化方法与DNA直接测序法对比的敏感度与特异度。结果10篇文献纳入meta分析，L858R 1,679例，E746-A750del 1,041例，诊断比值比（diagnositic odds ratio, DOR）分别为225.17（95%CI：55.67-910.69）和267.16（95%CI：132.45-538.88）；SROC曲线AUC分别为0.948,4（SEAUC=0.014,4）和0.981,3（SEAUC=0.009,9），Q＊统计量分别为0.888,3（SEQ＊=0.019,2）和0.9397（SEQ＊=0.019,1）。结论以上两种特异性抗体IHC鉴别EGFR突变的特异度高，灵敏度较高，作为筛查突变方法可行性高，具有一定的临床应用价值。 |
|---|---|
| AbstractList | 背景与目的已有的研究表明：表皮生长因子受体（epidermal growth factor receptor, EGFR）基因突变是非小细胞肺癌（non-small cell lung cancer, NSCLC）患者应用表皮生长因子受体酪氨酸激酶抑制剂（EGFR tyrosine kinase inhibitor, EGFR-TKI）治疗疗效的最重要的预测因子。EGFR基因突变的患者对于使用TKIs分子靶向药物治疗疗效更敏感。其突变检测对肺癌一线靶向治疗选择尤为关键。研究分析特异性抗体免疫组化法（immunohistochemistry, IHC）检测EGFR突变与DNA测序法比较的敏感度与特异度，明确该方法准确性及临床应用价值。方法通过Pubmed数据库检索所有符合检索条件的文献，末次检索日期2013年3月26日，根据纳入和排除标准进行进一步筛选，采用诊断试验meta分析方法，分析特异性抗体免疫组化方法与DNA直接测序法对比的敏感度与特异度。结果10篇文献纳入meta分析，L858R 1,679例，E746-A750del 1,041例，诊断比值比（diagnositic odds ratio, DOR）分别为225.17（95%CI：55.67-910.69）和267.16（95%CI：132.45-538.88）；SROC曲线AUC分别为0.948,4（SEAUC=0.014,4）和0.981,3（SEAUC=0.009,9），Q*统计量分别为0.888,3（SEQ*=0.019,2）和0.9397（SEQ*=0.019,1）。结论以上两种特异性抗体IHC鉴别EGFR突变的特异度高，灵敏度较高，作为筛查突变方法可行性高，具有一定的临床应用价值。 背景与目的已有的研究表明：表皮生长因子受体（epidermal growth factor receptor, EGFR）基因突变是非小细胞肺癌（non-small cell lung cancer, NSCLC）患者应用表皮生长因子受体酪氨酸激酶抑制剂（EGFR tyrosine kinase inhibitor, EGFR-TKI）治疗疗效的最重要的预测因子。EGFR基因突变的患者对于使用TKIs分子靶向药物治疗疗效更敏感。其突变检测对肺癌一线靶向治疗选择尤为关键。研究分析特异性抗体免疫组化法（immunohistochemistry, IHC）检测EGFR突变与DNA测序法比较的敏感度与特异度，明确该方法准确性及临床应用价值。方法通过Pubmed数据库检索所有符合检索条件的文献，末次检索日期2013年3月26日，根据纳入和排除标准进行进一步筛选，采用诊断试验meta分析方法，分析特异性抗体免疫组化方法与DNA直接测序法对比的敏感度与特异度。结果10篇文献纳入meta分析，L858R 1,679例，E746-A750del 1,041例，诊断比值比（diagnositic odds ratio, DOR）分别为225.17（95%CI：55.67-910.69）和267.16（95%CI：132.45-538.88）；SROC曲线AUC分别为0.948,4（SEAUC=0.014,4）和0.981,3（SEAUC=0.009,9），Q＊统计量分别为0.888,3（SEQ＊=0.019,2）和0.9397（SEQ＊=0.019,1）。结论以上两种特异性抗体IHC鉴别EGFR突变的特异度高，灵敏度较高，作为筛查突变方法可行性高，具有一定的临床应用价值。 |
| Abstract_FL | Background and objective It has been proven that epidermal growth factor receptor (EGFR) mutation is the most important predictive factor for determining the effect of EGFR tyrosine kinase inhibitors (TKIs) applied to non-small cell lung cancer (NSCLC) patients. hTe patients with EGFR mutations response better to TKIs. To detect EGFR muta-tion has been particularly essential to select ifrst-line treatment for lung cancer patients. To research and analyze the sensitivity and speciifcity of immunohistochemistry (IHC) using mutation speciifc antibodies in detecting EGFR mutations compared with DNA sequencing, and further evaluate the accuracy and clinical application value of IHC. Methods All required articles in Pubmed database were searched. hTe deadline of retrieval was March 26, 2013. hTen further screening the articles based on the inclusion and exclusion criteria. Meta analysis of diagnostic test was applied to analyze the sensitivity and speciifcity of IHC compared with DNA sequencing for the detection of EGFR mutations. Results Ten articles were included in the meta analysis, there were 1,679 samples in L858R group and 1,041 samples in E746-A750del group. hTe DOR were 225.17 (95%CI:55.67-910.69) and 267.16 (95%CI:132.45-538.88) respectively;the AUC of SROC were 0.948,4 (SEAUC=0.014,4) and 0.981,3 (SEAUC=0.009,9) respectively;the Q values were 0.888,3 (SEQ*=0.019,2) and 0.939,7 (SEQ*=0.019,1) respectively. Conclusion hTe speciifcity and sensitivity of IHC method using these two mutation-speciifc antibodies were relatively high. As a screening method for EGFR mutations, the IHC with mutation speciifc antibodies is of clinical value. |
| Author | 马晴 王竞 钟殿胜 宁超 刘畅 肖平 |
| AuthorAffiliation | 天津医科大学总医院肿瘤科,天津300052 天津医科大学总医院、天津市肺癌研究所,天津300052 |
| AuthorAffiliation_xml | – name: 天津医科大学总医院肿瘤科,天津,300052%300052天津，天津医科大学总医院，天津市肺癌研究所%300052天津，天津医科大学总医院肿瘤科; 300052天津，天津医科大学总医院，天津市肺癌研究所 |
| Author_FL | Qing MA Chao NING Diansheng ZHONG Chang LIU Jing WANG Ping XIAO |
| Author_FL_xml | – sequence: 1 fullname: Qing MA – sequence: 2 fullname: Jing WANG – sequence: 3 fullname: Diansheng ZHONG – sequence: 4 fullname: Chao NING – sequence: 5 fullname: Chang LIU – sequence: 6 fullname: Ping XIAO |
| Author_xml | – sequence: 1 fullname: 马晴 王竞 钟殿胜 宁超 刘畅 肖平 |
| BookMark | eNo1z81Kw0AUBeBBKthWH0JcuEq885NJZllKW4WCIN2XySSpLXaqjSJ2VaWKvyiIVVy4cSHoUkSk9W2a5DWMVFf3LD7O4eZQRne0j9ASBpPatlhpmc0w1CYGEAZlWJgEMDOBm0BnUBYLIQyOHTuT5n8yh3Jh2ALgRFCWRYXk7CsaH8X9l_j8fvJ9Gx1fJcO3ZDSILofx-1383I8_LkqV8kbyehhdP0xGn1F_nDwO2v6ujE5P4qebeTQbyK3QX_i7eVQrl2rFVaO6XlkrFqqGshzLkJ6tPEmIcgA8wpVitlAugAOMeS62pYelL1UAgeABdjjhOEVSSkqx47KA5tHytHZf6kDqRr3V2evqdLDeawSy1_v9HDiAlcrFqVSbHd3YaaZ2u9tsy-5B3QICJEX0B7oNb9M |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3779/j.issn.1009-3419.2014.06.03 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Value of Immunohistochemical Staining with Mutation-specific Antibodies in Detecting EGFR Mutations： A Meta-analysis |
| DocumentTitle_FL | Value of Immunohistochemical Staining with Mutation-speciifc Antibodies in Detecting EGFR Mutations:A Meta-analysis |
| EISSN | 1999-6187 |
| EndPage | 459 |
| ExternalDocumentID | zgfazz201406005 50202600 |
| GrantInformation_xml | – fundername: 国家自然科学基金资助项目(No.30971307和No.81071915)资助This study was supported by the grants from National Natural Science Foundation of China (both to Diansheng ZHONG) funderid: (30971307, 81071915) |
| GroupedDBID | --- -05 04C 29R 2B. 2C~ 2RA 2WC 3V. 5GY 5VS 6PF 92F 92I 92L AAWTL ABUWG ACGFS AFKRA ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVBZV C1A CCEZO CCPQU CIEJG CQIGP CW9 DIK E3Z EBD EIHBH EMOBN EOJEC F5P GROUPED_DOAJ HYE IPNFZ KQ8 KWQ OBODZ OK1 PIMPY PQQKQ PROAC RIG RNS RPM TCJ TGQ U1G U5O W91 ~WA 4A8 93N PGMZT PHGZM PHGZT PMFND PSX |
| ID | FETCH-LOGICAL-c585-ad7cda22c800d26cc479cb008044db17ad1aeacf0f96f1862616ccaaa3318b4f3 |
| ISSN | 1009-3419 |
| IngestDate | Thu May 29 03:56:17 EDT 2025 Wed Feb 14 10:35:18 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Immunohistochemistry Meta analysis DNA测序 Meta分析 表皮生长因子受体 免疫组化 Epidermal growth factor receptor DNA sequencing |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c585-ad7cda22c800d26cc479cb008044db17ad1aeacf0f96f1862616ccaaa3318b4f3 |
| Notes | Immunohistochemistry; DNA sequencing; Epidermal growth factor receptor; Meta analysis Background and objective It has been proven that epidermal growth factor receptor （EGFR） mutation is the most important predictive factor for determining the effect of EGFR tyrosine kinase inhibitors （TKIs） applied to non-small cell lung cancer （NSCLC） patients. hTe patients with EGFR mutations response better to TKIs. To detect EGFR muta-tion has been particularly essential to select ifrst-line treatment for lung cancer patients. To research and analyze the sensitivity and speciifcity of immunohistochemistry （IHC） using mutation speciifc antibodies in detecting EGFR mutations compared with DNA sequencing, and further evaluate the accuracy and clinical application value of IHC. Methods All required articles in Pubmed database were searched. hTe deadline of retrieval was March 26, 2013. hTen further screening the articles based on the inclusion and exclusion criteria. Meta analysis of diagnostic test was applied to analyze the |
| PageCount | 9 |
| ParticipantIDs | wanfang_journals_zgfazz201406005 chongqing_primary_50202600 |
| PublicationCentury | 2000 |
| PublicationDate | 2014 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – year: 2014 text: 2014 |
| PublicationDecade | 2010 |
| PublicationTitle | 中国肺癌杂志 |
| PublicationTitleAlternate | Chinese Journal of Lung Cancer |
| PublicationTitle_FL | Chinese Journal of Lung Cancer |
| PublicationYear | 2014 |
| Publisher | 天津医科大学总医院肿瘤科,天津,300052%300052天津，天津医科大学总医院，天津市肺癌研究所%300052天津，天津医科大学总医院肿瘤科 300052天津，天津医科大学总医院，天津市肺癌研究所 |
| Publisher_xml | – name: 天津医科大学总医院肿瘤科,天津,300052%300052天津，天津医科大学总医院，天津市肺癌研究所%300052天津，天津医科大学总医院肿瘤科 – name: 300052天津，天津医科大学总医院，天津市肺癌研究所 |
| SSID | ssj0062934 ssib002262905 ssib044765436 ssib001103766 ssib038074678 ssib051369142 |
| Score | 1.9958606 |
| Snippet | 背景与目的已有的研究表明：表皮生长因子受体（epidermal growth factor receptor, EGFR）基因突变是非小细胞肺癌（non-small cell lung cancer, NSCLC）患者应用表皮生长... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 451 |
| SubjectTerms | DNA测序 Mcta分析 免疫组化 表皮生长因子受体 |
| Title | 特异性抗体免疫组化法检测EGFR突变价值的meta分析 |
| URI | http://lib.cqvip.com/qk/91098A/201406/50202600.html https://d.wanfangdata.com.cn/periodical/zgfazz201406005 |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1999-6187 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0062934 issn: 1009-3419 databaseCode: KQ8 dateStart: 20080101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1999-6187 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0062934 issn: 1009-3419 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1999-6187 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0062934 issn: 1009-3419 databaseCode: DIK dateStart: 19980101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1999-6187 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib044765436 issn: 1009-3419 databaseCode: M~E dateStart: 19980101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central (PMC) customDbUrl: eissn: 1999-6187 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0062934 issn: 1009-3419 databaseCode: RPM dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: East & South Asia Database customDbUrl: eissn: 1999-6187 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0062934 issn: 1009-3419 databaseCode: BVBZV dateStart: 19980101 isFulltext: true titleUrlDefault: https://search.proquest.com/eastsouthasia providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central Database Suite (ProQuest) customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1999-6187 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0062934 issn: 1009-3419 databaseCode: BENPR dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1NaxNBdEhTKF7ET2zVEtA5ha3Z3dndmeNOsrEILVIi9Bb2M7009SO95BSlip8oiFU8ePEg6FFEpPXfdDd_w_dmN5scSlFhWSYv771582Yy773JzBtCroNPAF5Bkmi-w4XGktjQBFg9Lea25ccRS0KOB5zX1u3VO-zWprVZmavM7FraHQQr4fDYcyX_06sAg37FU7L_0LMlUwBAGfoX3tDD8P6rPqaeQ7mgUlDPorJJuUE9G_cuuI4quFRAgVHZosJEHA5PC6mETV2JBSkpZ-qrJgKBSppUWFhwTWSFEPhWejfbG0jguuB8KoI2FVxxl1Q6CtJAIZA74LDtGBxThHLKFWPh0fzOzokzrIg5dVuIJiSK6XFshHQVF4FCIWFLtQyaCFWWdpN6grrw5CigBVZX-vBAWCWohBrriCUMKtqqRR6ywDqgjc06sgQQNodTCfqy6oXA2DAH1aBASiZUjoWqlubsSkl-NrWY1vEvIMxcl1u9HIb5F2y9MPcTW-DMjPnZiZ0VaXHj4pM4zvxg8kZlfrCClbJS3EDIVJZYc2p1y72QFjjseEvAHJk3cE2pSualt357Y-rU4lHO2SDbsA0xnaXxxgCwduUsypiD54VLfEs3baGzMqkaEOd7LSbiLZBrhew3TpAcc49s7fR798CjUgfc-onf7834Yp0z5HQRRNXc_BdxllSGW-fIwlqxTeQ8ccfPfqWHj7LRl-z5-6Pfb9PHr8b738YHe-nL_ez7u-zzKPvxAgf0-OvD9PWHo4Of6ehw_HEPh2z69En26c0F0ml7neaqVtwVooUQ8Gp-5ISRbxghxD-RYYchc0QYYDjEWBTojh_pPrgYSSMRdqJjFK8Dku_7Jti0gCXmRVLt7_TjS6RmNwK8wy2MMNYwrVjwiGOKKjtK4iSIG4tkqVRE926eEqY76cRFUis00y3miQfdYS_xh0PUZAMwrKWT6C-TU4iYr_FdIdXB_d34Kni9g2C5GBbLatXoD48ghQ8 |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E7%89%B9%E5%BC%82%E6%80%A7%E6%8A%97%E4%BD%93%E5%85%8D%E7%96%AB%E7%BB%84%E5%8C%96%E6%B3%95%E6%A3%80%E6%B5%8BEGFR%E7%AA%81%E5%8F%98%E4%BB%B7%E5%80%BC%E7%9A%84meta%E5%88%86%E6%9E%90&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E9%A9%AC%E6%99%B4+%E7%8E%8B%E7%AB%9E+%E9%92%9F%E6%AE%BF%E8%83%9C+%E5%AE%81%E8%B6%85+%E5%88%98%E7%95%85+%E8%82%96%E5%B9%B3&rft.date=2014&rft.issn=1009-3419&rft.eissn=1999-6187&rft.volume=17&rft.issue=6&rft.spage=451&rft.epage=459&rft_id=info:doi/10.3779%2Fj.issn.1009-3419.2014.06.03&rft.externalDocID=50202600 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91098A%2F91098A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg |